8 unchanged sentences
Stock Performance Graph -
−Removed: The following performance graph and related information shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, and shall not be incorporated by reference into any registration statement or other document filed by us with the SEC, whether made before or after the date of this Annual Report on Form 10-K, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.
+Added: The following performance graph and related information shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended, and shall not be incorporated by reference into any registration statement or other document filed by us with the SEC, whether made before or after the date of this Annual Report on Form 10-K, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific reference in such filing.
The following graph and related information shows a comparison of the cumulative total return for our common stock, Russell 2000 Index, and NASDAQ Health Care Index between April 28, 2021 (the date our common stock commenced trading on the NASDAQ) through December 31, 2024.
16 unchanged sentences
NASDAQ Health Care $ 62.61 $ 62.04 $ 58.45 $ 62.73
+Added: 3/31/2024 6/30/2024 9/30/2024 12/31/2024
+Added: Privia Health Group, Inc.
+Added: $ 56.37 $ 50.01 $ 52.40 $ 56.26
+Added: Russell 2000 $ 97.64 $ 94.44 $ 103.20 $ 103.54
+Added: NASDAQ Health Care $ 63.95 $ 63.66 $ 67.72 $ 61.13
(1) $100 invested on April 28, 2021 in shares and in indices
−Removed: The information above shall not be deemed “soliciting material” or to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934,as amended, or otherwise subject to the liabilities under that section, and shall not be incorporated by reference into any of our other filings under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, regardless of any general incorporation language in those filings.
+Added: The information above shall not be deemed “soliciting material” or to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that section, and shall not be incorporated by reference into any of our other filings under the Exchange Act, or the Securities Act of 1933, as amended, regardless of any general incorporation language in those filings.
Securities Authorized for Issuance under Equity Compensation Plans
7 unchanged sentences
Issuer Purchases of Equity Securities
−Removed: Use of Proceeds from Initial Public Offering
−Removed: On May 3, 2021, we completed our IPO pursuant to a Registration Statement (File No.
−Removed: 333-255086), which was declared effective on April 28, 2021.
−Removed: The Registration Statement registered an aggregate of 22,425,000 shares of our common stock at an aggregate offering price of $515.8 million.
−Removed: In the offering, we sold 5,725,000 shares of common stock at an aggregate offering price of $131.7 million and our majority stockholder sold 16,700,000 shares of our common stock at an aggregate offering price of $384.1 million.
−Removed: The number of shares sold by us included the full exercise of the underwriters’ option to purchase up to an additional 2,925,000 shares of common stock from us.
−Removed: Goldman Sachs & Co.
−Removed: Morgan Securities LLC acted as representatives of the underwriters for the offering.
−Removed: The offering commenced on April 26, 2021 and did not terminate before all of the securities registered in the Registration Statement were sold.
−Removed: We received net proceeds of approximately $211.0 million from the IPO and Anthem private placement after deducting underwriters’ discounts and commissions of $7.9 million and expenses of $4.8 million payable by us.
−Removed: We used a portion of the net proceeds from the IPO to voluntarily prepay approximately $33.1 million of indebtedness and accrued interest under the Term Loan Facility in June 2022.
−Removed: Other than the changes noted above, there have been no material changes in the planned use of proceeds from the IPO from those that were described in the final prospectus filed pursuant to Rule 424(b) under the Securities Act.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.